Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Nov 11, 2022 8:27pm
168 Views
Post# 35093029

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:how do the few longs feel about jd leaving you?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:how do the few longs feel about jd leaving you?Actually, beenthere, there is a book there, a kind of "The Soul of A New Machine" kind of book.I still have my 40-year-old copy of that book. The book was the account of the building of a new computer by Data General and it won a Pulitzer Prize.

I doubt very much that you would find it interesting, beenthere, given that you usually don't even read this far into a Stockhouse post, by your own admission.

I certainly have enough personal knowledge and background information to write the story. Thousands of documents, journals, emails, text messages - the story, waiting to be told.

Imagine a company that acquires a forgotten technology that can transport therapeutic payloads across a formidable barrier and into a new frontier, the central nervous system. The story of how, 15 years later, the barrier has yet to be crossed, and the frontier yet to be explored.. What frailties of humankind could prevent this great story from unfolding.

etc etc etc

I don't even need any imagination to tell this one. It would just unspool, all by itself.

jd
<< Previous
Bullboard Posts
Next >>